Cel-Sci Corp. (CVM)

May 18, 2026

CVM: CEL-SCI Advances Multikine Toward Regulatory Approval - GuruFocus

May 18, 2026

May 18, 2026

[RW] CEL SCI CORP SEC Filing - Stock Titan

May 18, 2026

May 18, 2026

Cel Sci CEO Geert Kersten’s trust buys $360,000 in common stock By Investing.com - Investing.com South Africa

May 18, 2026

May 18, 2026

Cel Sci CEO Geert Kersten’s trust buys $360,000 in common stock - Investing.com Australia

May 18, 2026

May 18, 2026

Cel Sci Insider Bought Shares Worth $360,000, According to a Recent SEC Filing - marketscreener.com

May 18, 2026

May 18, 2026

CEL-SCI (NYSE: CVM) trust buys 300K restricted shares at $1.20 - Stock Titan

May 18, 2026

May 18, 2026

CEL-SCI adds Saudi partner, U.S. trial for head and neck cancer drug - Stock Titan

May 18, 2026

May 15, 2026

Cel-Sci: Fiscal Q2 Earnings Snapshot - cbs19news.com

May 15, 2026

May 15, 2026

CEL SCI CORP 1H 2026: Net loss $(10.94M), Diluted EPS $(1.35) — 10-Q Summary - TradingView

May 15, 2026

May 15, 2026

CEL-SCI Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 - marketscreener.com

May 15, 2026

May 15, 2026

CEL-SCI (NYSE: CVM) reports $10.9M loss and just $1.9M in cash - Stock Titan

May 15, 2026

May 15, 2026

CEL-SCI Partners with Amarox for Multikine Cancer Immunotherapy Commercialization in Saudi Arabia and GCC Region 12 - Minichart

May 15, 2026

May 14, 2026

CEL-SCI (NYSE: CVM) partners with Amarox on Multikine in Saudi Arabia - Stock Titan

May 14, 2026

May 14, 2026

CEO Geert Kersten Increases Stake in CEL-SCI Corp with Recent Sh - GuruFocus

May 14, 2026

May 14, 2026

Cel-Sci Corporation Common Stock (NY: CVM - FinancialContent

May 14, 2026

May 14, 2026

CEO Geert Kersten Increases Stake in CEL-SCI Corp with Recent Share Purchase - GuruFocus

May 14, 2026

May 14, 2026

Cel Sci CEO Geert Kersten acquires $119,000 in common stock - Investing.com India

May 14, 2026

May 14, 2026

Cel Sci CEO Geert Kersten acquires $119,000 in common stock By Investing.com - Investing.com South Africa

May 14, 2026

May 14, 2026

CEL SCI (CVM) CEO Geert Kersten purchases 100,000 restricted shares - Stock Titan

May 14, 2026

May 13, 2026

CEL-SCI Raises $7.2 Million in Stock Offering; Placement Agreement With ThinkEquity - TradingView

May 13, 2026

May 13, 2026

CEL-SCI (NYSE: CVM) prices $7.2M best-efforts stock offering - Stock Titan

May 13, 2026

May 13, 2026

CEL-SCI closes $7.2M public offering at $1.20 per share - Investing.com

May 13, 2026

May 13, 2026

Cancer immunotherapy firm CEL-SCI raises $7.2M for Multikine - Stock Titan

May 13, 2026

May 13, 2026

CEL‑SCI (NYSE American: CVM) to sell 6.0M shares; raises ~$6.5M net - Stock Titan

May 13, 2026

May 13, 2026

Cel-Sci Corp files for offering of 6 million shares of common stockSEC filing - marketscreener.com

May 13, 2026

May 13, 2026

Cel-Sci Corp Files For Offering Of 6 Million Shares Of Common Stock- SEC Filing - TradingView

May 13, 2026

May 12, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

May 12, 2026

May 12, 2026

Get insights into the top gainers and losers of Tuesday's pre-market session. - ChartMill

May 12, 2026

May 12, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

May 12, 2026

May 12, 2026

[EFFECT] CEL SCI CORP SEC Filing - Stock Titan

May 12, 2026

May 12, 2026

Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

May 12, 2026

May 12, 2026

Why Did CEL-SCI Stock Plunge After Its Latest Offering - Kavout

May 12, 2026

May 12, 2026

CVM: ThinkEquity Completes Sole Management of Offering - GuruFocus

May 12, 2026

May 11, 2026

CEL-SCI prices $7.2M public offering at $1.20 per share By Investing.com - Investing.com South Africa

May 11, 2026

May 11, 2026

CEL-SCI prices $7.2M public offering at $1.20 per share - Investing.com

May 11, 2026

May 11, 2026

Cancer immunotherapy firm CEL-SCI seeks $7.2M to develop Multikine - Stock Titan

May 11, 2026

May 11, 2026

CEL-SCI Corporation Announces Pricing of Public Offering - Yahoo Finance

May 11, 2026

May 11, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

May 11, 2026

May 11, 2026

Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill

May 11, 2026

May 11, 2026

Strategic Partnership for CEL-SCI (CVM) Enhances Multikine's Mar - GuruFocus

May 11, 2026

May 11, 2026

CEL-SCI partners with Amarox for Multikine in Saudi Arabia By Investing.com - Investing.com South Africa

May 11, 2026

May 11, 2026

CEL-SCI partners with Amarox for Multikine in Saudi Arabia - Investing.com India

May 11, 2026

May 11, 2026

Saudi bid to fast-track cancer immunotherapy with new CEL-SCI deal - Stock Titan

May 11, 2026

May 08, 2026

Cel-Sci CVM shares surge 10% after Q4 earnings beat; quarterly loss narrower than analysts expected.Balance Sheet - newser.com

May 08, 2026

May 04, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

May 04, 2026

May 01, 2026

EDGAR Filing Documents for 0001654954-26-004295 - SEC.gov

May 01, 2026

May 01, 2026

CEL-SCI (NYSE: CVM) moves to fund Multikine with $13.7M best efforts stock sale - Stock Titan

May 01, 2026

Apr 29, 2026

CVM - Finviz

Apr 29, 2026

Apr 28, 2026

New LowStock ScreenerSnapshot - Finviz

Apr 28, 2026

Apr 20, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 20, 2026

Apr 19, 2026

Eom Pharmaceutical Holdings Inc (IMUC) - MSN

Apr 19, 2026